Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Axokine use in retinal degeneration covered in new patent

Sep. 23, 1997

Initial phase III results reported for KeraVision Ring

Sep. 17, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997

Tolmetin eyedrop formulation evaluated in rabbits

Sep. 9, 1997

Improved IOP-lowering prostaglandin analogues from Alcon

Sep. 4, 1997

Alcon reports new agents for controlling IOP

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...